Skip to main content
    G

    Gain Therapeutics Inc (GANX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.94
    -0.10 (-9.60%)

    Market Cap: $46.31M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Gain Therapeutics Inc (GANX) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Gain Therapeutics (GANX) is expected to report earnings on Mar 24, 2027. In the quarter ended Sep 30, 2026, Gain Therapeutics reported EPS of -$0.07, above the -$0.13 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    52%(12/23)
    Avg Surprise
    -10.72%
    Streak
    4 Q

    Upcoming Estimates

    Reports Mar 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.13
    Range-$0.16 - -$0.08
    6 analysts
    Revenue Consensus
    N/A
    RangeN/A
    7 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.12
    Range-$0.13 - -$0.11
    3 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.13+4.0%
    60d ago-$0.13+4.0%
    30d ago-$0.13+5.3%
    7d ago-$0.13+5.3%
    Current-$0.12
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Next Report

    GANX has an expected report date of Mar 24, 2027.

    Earnings History

    Of the 23 quarters below that had an estimate, GANX beat 12, missed 10 and matched 1. The widest gap in the table came in the quarter ended Mar 31, 2021, when EPS landed 284.62% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.07-$0.13-$0.13 - -$0.12+46.15%BeatN/A40 up, 0 downNov 10, 2026N/A
    Jun 30, 2026-$0.11-$0.14-$0.18 - -$0.13+21.43%BeatN/A40 up, 0 downAug 11, 2026N/A
    Mar 31, 2026-$0.13-$0.14-$0.15 - -$0.13+7.14%BeatN/A32 up, 0 downMay 11, 2026N/A
    Dec 31, 2025-$0.11-$0.14-$0.15 - -$0.12+23.77%BeatN/A41 up, 0 downMar 26, 2026N/A
    Sep 30, 2025-$0.15-$0.15-$0.16 - -$0.140.00%In lineN/A32 up, 1 downNov 12, 2025N/A
    Jun 30, 2025-$0.19-$0.17N/A-11.76%MissN/A52 up, 1 downAug 12, 2025N/A
    Mar 31, 2025-$0.16-$0.17-$0.22 - -$0.14+5.88%BeatN/A41 up, 0 downMay 14, 2025N/A
    Dec 31, 2024-$0.08-$0.19-$0.23 - -$0.17+57.33%BeatN/A42 up, 0 downMar 27, 2025$82242
    Sep 30, 2024-$0.17-$0.21-$0.23 - -$0.18+19.05%BeatN/A31 up, 0 downNov 14, 2024N/A
    Jun 30, 2024-$0.42-$0.22-$0.23 - -$0.16-90.91%MissN/A30 up, 0 downAug 8, 2024N/A
    Mar 31, 2024-$0.22-$0.33-$0.39 - -$0.19+33.33%BeatN/A40 up, 0 downMay 14, 2024N/A
    Dec 31, 2023-$0.36-$0.32-$0.40 - -$0.26-12.50%MissN/A40 up, 0 downMar 26, 2024$64800
    Sep 30, 2023-$0.37-$0.46-$0.51 - -$0.38+19.57%BeatN/A50 up, 0 downNov 14, 2023N/A
    Jun 30, 2023-$0.62-$0.38-$0.41 - -$0.10-63.16%MissN/A40 up, 0 downAug 10, 2023N/A
    Mar 31, 2023-$0.43-$0.39-$0.41 - -$0.37-10.26%MissN/A30 up, 0 downMay 12, 2023$55180
    Dec 31, 2022-$0.39-$0.36-$0.42 - -$0.33-8.33%MissN/A40 up, 0 downMar 23, 2023$140108
    Sep 30, 2022-$0.38-$0.46-$0.54 - -$0.39+17.39%BeatN/A40 up, 0 downNov 10, 2022N/A
    Jun 30, 2022-$0.43-$0.31-$0.33 - -$0.29-38.71%MissN/A31 up, 0 downAug 8, 2022$95102
    Mar 31, 2022-$0.28-$0.37-$0.43 - -$0.28+24.32%BeatN/A41 up, 0 downMay 16, 2022$45006
    Dec 31, 2021-$0.26-$0.49-$0.51 - -$0.47+46.94%BeatN/A30 up, 0 downMar 24, 2022$70552
    Sep 30, 2021-$0.39-$0.33-$0.40 - -$0.28-18.18%MissN/A22 up, 0 downNov 12, 2021N/A
    Jun 30, 2021-$0.30-$0.23N/A-30.43%MissN/A2N/AAug 11, 2021$89173
    Mar 31, 2021-$0.50-$0.13N/A-284.62%MissN/A2N/AMay 10, 2021$5269
    Dec 31, 2020Not reportedN/AN/AN/ANot reportedN/AN/AN/AMar 22, 2021$9139
    Sep 30, 2020-$0.41N/AN/AN/AN/AN/AN/AN/ADec 31, 2020$6696
    Sep 30, 2019-$0.32N/AN/AN/AN/AN/AN/AN/ADec 31, 2019$10325
    Last 26 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.61, after -$0.89 the year before. It was -$0.73 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.61N/A
    Dec 31, 2024-$0.89N/A
    Dec 31, 2023-$1.78N/A
    Dec 31, 2022-$1.48N/A
    Dec 31, 2021-$1.45N/A
    Dec 31, 2020-$0.73N/A

    Frequently Asked Questions About GANX

    When is Gain Therapeutics's next earnings date?

    Gain Therapeutics's next earnings report is expected for Mar 24, 2027.

    Did GANX beat earnings estimates last quarter?

    Yes. Gain Therapeutics reported EPS of -$0.07 for the quarter ended Sep 30, 2026, above the -$0.13 estimate, a 46.15% surprise.

    What EPS do analysts expect from GANX next quarter?

    The consensus EPS estimate for Gain Therapeutics for the quarter ending Dec 31, 2026 is -$0.13 from 6 analysts, with estimates from -$0.16 to -$0.08.

    How often does GANX beat earnings estimates?

    Gain Therapeutics beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +18.74%.